Viewing by:
Cryopreservation should maintain the function and viability of organs and cell therapies, but the process is riddled with challenges. Can nature-inspired proteins make a difference?
The organ transplantation field has experienced numerous barriers which have contributed to the creation of organ accessibility issues worldwide. To help tackle these challenges, X-Therma
The preservation of living cells and tissues is an often-underappreciated obstacle in the clinical lab. Cryogenic temperatures attempt to address this challenge by minimizing biochemical
While traditional biologics continue to see strong market demand, the need for emerging therapies, such as regenerative medicines, has also given rise to a burgeoning
X-Therma Inc., a biotechnology company developing breakthrough technology for regenerative medicine and organ preservation – announced today that The Center for Devices and Radiological Health (CDRH)
In the past two years, the cold chain turned into one of the most talked-about aspects of healthcare. Biotechnology company X-Therma in Richmond, CA, plans
Every day it seems you can find a headline somewhere describing the extraordinary progress scientists have made in developing cell and gene therapies for rare
Existing and emerging biotech advances are transforming the way we preserve and transport donated organs. While their methods may vary, all share a common end
Living cells, tissues, and organs are more critical to medicine than ever before, but current cryopreservation techniques are not enough to keep these materials viable
RICHMOND, Calif. — December 22, 2021 — 6:00 AM PT — X-Therma Inc., a biotechnology company developing breakthrough technology for regenerative medicine and organ preservation – has closed an
X-Therma, Inc.
2600 Hilltop Drive
Suite B220
Richmond, CA 94806
USA
Kaiserjägerstraße 30
6020 Innsbruck
Austria
"*" indicates required fields
2600 Hilltop Drive
Suite B220
Richmond, CA 94806
USA
Kaiserjägerstraße 30
6020 Innsbruck
Austria
